Eleven Chinese COVID-19 vaccines have entered the clinical trial phase, four of them are in phase-3, Beijing News reported on Friday, citing Wang Zhigang, minister of science and technology at a health forum in Beijing.
There are still possibilities of epidemic rebound as autumn and winter approach, said Wang, adding that the situation of epidemic prevention and control remains grim.
